Color Code
Yellow

Meningitis Carriage Study in Burkina Faso

930
Burkina Faso
Meningitis Carriage Study in Burkina Faso
Burkina Faso
To conduct an evaluation of N. Meningitidis and N. Lactamica in Burkina Faso as part of a larger initiative to introduce a novel serogroup A conjugate meningococcal vaccine in Africa and eliminate epidemic meningitis.
Bill & Melinda Gates Foundation
CDC's National Center for Immunization and Respiratory Diseases; Norwegian Institute of Public Health

Data to Action and Monitoring Tobacco Use in Asia

761
Cambodia
Data to Action and Monitoring Tobacco Use in Asia
China, Indonesia, Philippines, Thailand, Vietnam
China
Indonesia
Philippines
Thailand
Viet Nam
To build and enhance tobacco use surveillance and research capacity in Southeast Asia and China by expanding the Global Tobacco Surveillance System (GTSS). The GTSS will enable countries in the region to produce globally standardized tobacco use data and track key tobacco control measures among the region's adult populations. Funding is provided by the Bill & Melinda Gates Foundation through the Bloomberg Initiative to Reduce Tobacco Use.
Bill & Melinda Gates Foundation funded through the Bloomberg Philanthropies’ Bloomberg Initiative to Reduce Tobacco Use
World Health Organization; Johns Hopkins Bloomberg School of Public Health; Campaign for Tobacco Free Kids; The Union; Vital Strategies; RTI International; CDC National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Global Tobacco Control Branch

Vaccine Induced Immune Responses to Plasmodial Antigens

706
global health
Vaccine Induced Immune Responses
United States of America
To support an immunization and chade Beaumontllenge trial of CDC's P. falciparum chimeric MSP1/8 vaccine in nonhuman primates. The specific model will involve studies in the monkey species Aotus nancymaae using the P. falciparum FVO strain.
Drexel University
CDC’s Center for Global Health

Rotavirus Breast Milk Analysis

862
mom and baby
Rotavirus Breast Milk Analysis
United States of America
To collect breast milk in mothers with infants less than 6 months of age in developing and developed countries in order to maximize levels of antibody response to rotavirus and compare the inhibitory effect of maternal antibodies on vaccine strains.
Emory National Science & Technology Council; Glaxo SmithKline Biologicals s.a.
CDC's National Center for Immunization and Respiratory Diseases

Global Monitoring of the Tobacco Epidemic

Global TobaccoTobacco is the leading cause of preventable disease and death worldwide. More than seven million people die each year due to tobacco related illnesses—a figure expected to rise to more than eight million a year by 2030. According to the World Health Organization (WHO), nearly 80 percent of the world’s one billion smokers live in low- and middle-income countries. Robust monitoring helps countries tailor best practices to combat the epidemic.

Expanding CDC’s Global Tobacco Surveillance System

The Global Tobacco Surveillance System (GTSS), comprised of the Global Adult Tobacco Survey (GATS), the Global Youth Tobacco Survey (GYTS), and Tobacco Questions for Surveys (TQS), provides globally standardized data to track adult and youth tobacco use prevalence and trends across the world. The CDC Foundation supports the work of CDC, the World Health Organization (WHO), and other international partners in implementing select components of GTSS.

GATS, a nationally representative household survey of adults aged 15 years and older, is the global standard to systematically monitor adult tobacco use and track key tobacco control indicators. The survey is intended to generate comparable data within and across countries and enhances a country's capacity to design, implement, and evaluate tobacco control interventions. GATS surveys completed to date provide globally comparable data for more than 790 million adult smokers, which represents more than 68 percent of the world’s adult smoking population.

To promote global comparability of adult tobacco use data, TQS was developed to provide countries with a standard set of tobacco use questions for inclusion in ongoing national and sub-national surveys. TQS are a subset of GATS and are intended to harmonize international tobacco surveillance and monitoring activities across a variety of different surveillance systems.

GYTS, a school-based survey that collects data on students aged 13–15 years, is intended to enhance a country’s capacity to design, implement, and evaluate youth tobacco control and prevention programs.

In addition to funding, the CDC Foundation provides logistical and administrative support, including managing contracts and procurement, convening subject matter experts and partners, working with WHO and CDC to support survey implementation, and helping operationalize CDC’s vision for global tobacco surveillance.

Helping CDC Build tobacco Control Capacity

Building on the success of GTSS, the CDC Foundation received additional funding to help CDC use GTSS data to build research, epidemiology, and policy capacity globally. The CDC Foundation supports CDC in establishing tobacco control fellowships and implementing Data to Action workshops to build in-country tobacco control capacity. These programs are intended to use GTSS data to inform tobacco control policies and generate an evidence base for advancing tobacco control policies, programs, and research.

GTSS Funding Support

  • The Bloomberg Initiative to Reduce Tobacco Use, with grants from Bloomberg Philanthropies, supports GATS and TQS globally.
  • Select countries have self-funded GTSS surveys or provided in-kind support.
357
Global Tobacco
Global Monitoring of the Tobacco Epidemic
United Arab Emirates
Armenia
Azerbaijan
Bangladesh
Benin
Brazil
Bhutan
Cameroon
China
Costa Rica
Algeria
Egypt
Ghana
Greece
Guatemala
Croatia
Indonesia
India
Iraq
Kyrgyzstan
Cambodia
Kazakhstan
Sri Lanka
Morocco
Myanmar
Mexico
Niger
Nigeria
Panama
Philippines
Pakistan
Qatar
Romania
Russian Federation
Saudi Arabia
Slovenia
Slovakia
Sierra Leone
Chad
Tajikistan
Timor-Leste
Turkmenistan
Turkey
Ukraine
Uruguay
Uzbekistan
Viet Nam
To create, launch and expand, as a component of the Bloomberg Initiative to Reduce Tobacco Use, a standard global surveillance system to monitor adult tobacco use and key tobacco control measures in countries with the highest burden from the tobacco epidemic. These data will be used to develop, implement and evaluate tobacco control policies and interventions that can reduce tobacco use at the national and global levels.
Bloomberg Philanthropies
CDC's National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Global Tobacco Control Branch; World Health Organization; Johns Hopkins Bloomberg School of Public Health; Campaign for Tobacco Free Kids; The Union; Vital Strategies; RTI International

Supporting Water & Hygiene in Mali

836
safe water
Supporting Water & Hygiene in Mali
Mali
To provide both rapid and sustainable access to water to an estimated 66,000 people in healthcare facilities in marginalized, rural, trachoma-endemic communities in Mali.
The Conrad N. Hilton Foundation
CDC’s National Center for Emerging and Zoonotic Infectious Diseases

Controlling Mosquito Vectors of Malaria

831
malaria
Controlling Mosquito Vectors of Malaria
Burkina Faso, Mali, Uganda
Burkina Faso
United Kingdom
Mali
Uganda
To develop data that will contribute to an assessment of whether transgenic mosquitoes could be effectively and safely deployed to control natural populations of malaria vectors.
Imperial College of London
CDC’s Center for Global Health; Bill & Melinda Gates Foundation

Data for Health

826
data for health
Data for Health
Bangladesh, Columbia, China, Ecuador, Ghana, India, Malawi, Morocco, Myanmar, Philippines, Rwanda, Tanzania, Zambia, Kenya, South Africa
Bangladesh
China
Colombia
Ecuador
Ghana
India
Kenya
Morocco
Myanmar
Malawi
Philippines
Rwanda
Tanzania
South Africa
Zambia
To assist 20 low- and middle-income countries across Latin America, Asia and Africa in strengthening their public health data systems and data use for critical policy-making decisions.
Bloomberg Philanthropies
CDC’s Center for Global Health; World Health Organization; Johns Hopkins Bloomberg School of Public Health; University of Melbourne; Vital Strategies (formerly The Union North America)

Pneumococcal Disease in Qatar

789
pneumoccal
Pneumococcal Disease in Qatar
Qatar
To evaluate the impact of Pneumococcal Conjugate Vaccine (PCV-13) on vaccine and non-vaccine serotypes causing both invasive and non-invasive diseases in Qatar. The study also assesses the overall prevalence and serotype distribution of S.pneumoniae nasopharyngeal carriage in both healthy and sick children below five years of age over a three-year period.
Hamad Medical Corporation
CDC's National Center for Immunization and Respiratory Diseases
Subscribe to Global Health